Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
Editas' gene-editing data has company touting prime time based on early vision improvement signals but questions remain
Fierce Biotech
Wed, 09/29/21 - 11:12 am
CRISPR
Editas Medicine
gene editing
EDIT-101
vision loss
FDA clears first-of-its-kind trial to see if CRISPR gene editing can cure HIV
Endpoints
Wed, 09/15/21 - 10:26 pm
Excision BioTherapeutics
CRISPR
clinical trials
HIV
gene editing
Eli Lilly Pursues RNA Editing in New Partnership with ProQR
Xtalks
Mon, 09/13/21 - 10:43 am
Eli Lilly
RNA
gene editing
ProQR Therapeutics
Why Vertex Is Expanding a Gene-Editing Partnership -- and It's not With CRISPR Therapeutics
Motley Fool
Mon, 09/6/21 - 09:03 pm
Vertex Pharmaceuticals
CRISPR
gene editing
Arbor Biotechnologies
Vertex boosts cell and genetic therapies toolkit in deal worth up to $1.2bn with Arbor
Biopharma Reporter
Mon, 08/30/21 - 10:57 am
Vertex
cell therapy
gene therapy
CRISPR
gene editing
Arbor Biotechnologies
Vertex, looking to broaden its gene editing abilities, asks a young biotech for help
BioPharma Dive
Tue, 08/24/21 - 11:02 pm
Vertex Pharmaceuticals
gene editing
Arbor Pharmaceuticals
Will Moderna Buy Editas Medicine to Jump Into Gene Editing?
Motley Fool
Thu, 08/12/21 - 11:22 am
Moderna Therapeutics
gene editing
Editas Medicine
M&A
Caribou raises $304M in one of gene editing's most lucrative IPOs
BioPharma Dive
Sat, 07/24/21 - 06:34 pm
Caribou Biosciences
CRISPR
gene editing
IPOs
World Health Organization advisers urge global effort to regulate genome editing
Stat
Mon, 07/12/21 - 10:48 am
WHO
gene editing
Hitting landmark milestone, Intellia shows CRISPR can edit genes directly in patients
Endpoints
Sun, 06/27/21 - 12:03 am
Intellia
gene editing
CRISPR
8 key clinical trials to watch for the rest of 2021
BioPharma Dive
Mon, 06/21/21 - 11:11 am
clinical trials
Merck
Ridgeback Biotherapeutics
COVID-19
Intellia Therapeutics
transthyretin amyloidosis
Arcus Biosciences
Gilead Sciences
lung cancer
Sanofi
GSK
vaccines
uniQure
Huntington's disease
Mirati Therapeutics
gene editing
Seres Therapeutics
ulcerative colitis
Sarepta Therapeutics
Duchenne Muscular Dystrophy
CRISPR Therapeutics takes a swing at ALS gene editing in discovery deal with AAV upstart Capsida
Endpoints
Tue, 06/15/21 - 10:37 am
CRISPR Therapeutics
ALS
gene editing
Capsida
Gene editing biotech Verve indicates a swift swerve onto Wall Street, asking for $100M IPO
Fierce Biotech
Tue, 06/1/21 - 10:50 pm
Verve Therapeutics
IPOs
gene editing
heart disease
Vertex adds a new gene editing partner, paying Obsidian $75M for controllable CRISPR system
Endpoints
Thu, 04/22/21 - 10:54 am
Vertex Pharmaceuticals
gene editing
CAR-T
Obsidian
Vertex puts a blockbuster valuation on its CRISPR deal
EP Vantage
Tue, 04/20/21 - 11:05 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
CTX001
M&A
The continuing CRISPR patent saga
Endpoints
Thu, 04/8/21 - 10:27 am
gene editing
CRISPR
patents
Intellia announced a new tool for gene editing. Academics said they rewrote history
Endpoints
Tue, 03/30/21 - 10:16 pm
CRISPR
gene editing
Intellia Therapeutics
With all the buzz in gene therapy, Sanofi offloads two small molecule sickle cell programs from $11.6B buyout to Global Blood Therapeutics
Endpoints
Tue, 03/16/21 - 10:55 am
Sanofi
sickle cell disease
gene therapy
gene editing
Global Blood Therapeutics
UCSD spinout pursues gene therapy for chronic pain following positive data in mice
Fierce Biotech
Fri, 03/12/21 - 10:19 am
UCSD
chronic pain
non-opioid pain treatments
gene editing
Doudna-founded biotech Caribou raises fresh funds to fuel gene editing pipeline
BioPharma Dive
Wed, 03/3/21 - 11:00 am
Caribou Biosciences
Jennifer Doudna
CRISPR
gene editing
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »